HTA Database - Search Results

Sort by Relevance

Search Results [314 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2022	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Efficacy and safety of transanal irrigation in adults with bowel dysfunction]
2022	Malaysian Health Technology Assessment (MaHTAS)	Robotic arm-assisted surgery in total hip arthroplasty, total knee arthroplasty and unicompartmental knee arthroplasty
2022	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Bronchial thermoplasty in severe asthma]
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: helicopter emergency medical services (HEMS) - needs analysis and clientele identification]
2022	Health Technology Wales (HTW)	Virtual reality interventions for the management of pain associated with medical procedures
2022	Norwegian Institute of Public Health (NIPH)	[Transcranial direct current stimulation for depression and aphasia. A health technology assessment]
2022	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Selumetinib (neurofibromatosis (≥ 3 to < 18 years, type 1))]
2022	Norwegian Institute of Public Health (NIPH)	Zephyr® valves system in the treatment of emphysema: a single technology assessment
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vagus nerve stimulation for drug-resistant epilepsy]
2021	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Sentinel lymph node biopsy in oral cavity carcinoma: clinical effectiveness, safety, and cost-effectiveness]
2021	Health Technology Wales (HTW)	Transcranial magnetic stimulation for the treatment of depression
2021	Swiss Federal Office of Public Health (FOPH)	Statins in the primary prevention of cardiovascular events and mortality in Switzerland
2021	NIHR Health Technology Assessment programme	Prognostic models of survival in patients with advanced incurable cancer: the PiPS2 observational study
2021	NIHR Health Technology Assessment programme	Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation
2021	Malaysian Health Technology Assessment (MaHTAS)	Delirium unit in geriatric ward
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: initiating blood work for the purpose of evaluating diagnosed or suspected alcohol use disorder]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: efficacy and safety of pharmacological treatments for alcohol withdrawal and relapse prevention]
2021	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Osilodrostat (Endogenous Cushing’s Syndrome)]
2021	Canary Health Service	[Molecular markers for the detection of clinically significant prostate cancer]
2021	Ontario Health	Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment
2021	Swiss Federal Office of Public Health (FOPH)	Medical cannabis for treating various symptoms in Switzerland
2021	Swiss Federal Office of Public Health (FOPH)	Subacromial decompression as a primary/isolated intervention to treat subacromial pain
2021	NIHR Health Technology Assessment programme	Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis
2021	Ontario Health	Vaginal pessaries for pelvic organ prolapse and stress urinary incontinence
2020	NIHR Health Services and Delivery Research programme	UK Study of tendon Achilles Rehabilitation multicentre randomised clinical trial (UK STAR)
2020	Malaysian Health Technology Assessment (MaHTAS)	Programmatic management of latent tuberculosis infection
2020	Swiss Federal Office of Public Health (FOPH)	Iron therapy for iron deficiency without anemia
2020	NIHR Health Technology Assessment programme	Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation
2020	National Committee for Technology Incorporation (CONITEC)	[Tofacitinib citrate for the treatment of moderate to severe ulcerative colitis in adult patients with inadequate response, loss of response or intolerance to previous treatment with conventional synthetic or biological drugs]
2020	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dupilumab in atopic dermatitis not adequately controlled with atopical therapy]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: prevention of cardiovascular events and safety of SGLT2 inhibitors compared to DPP-4 inhibitors in a real-world setting in patients with type 2 diabetes]
2020	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Burosumab (new therapeutic indication: X-linked hypophosphataemia, ≥ 18 years)]
2020	Andalusian Health Technology Assessment Area (AETSA)	Genetic risk prediction test for cardiovascular disease
2020	NIHR Health Technology Assessment programme	Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Efficacy and safety of mechanical thrombectomy in the treatment of patients with ischaemic stroke beyond 6 hours after onset or with an unknown time of onset]
2019	NIHR Health Technology Assessment programme	Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
2019	Norwegian Institute of Public Health (NIPH)	Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment
2019	Norwegian Institute of Public Health (NIPH)	Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury
2019	Norwegian Institute of Public Health (NIPH)	Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
2019	Swiss Federal Office of Public Health (FOPH)	Removal of osteosynthesis materials (e.g. screws, plates, nails and wires) used to treat bone fractures
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Impact of postmastectomy radiotherapy on complications and results of immediate breast reconstruction
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Shear-wave elastography for liver fibrosis]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Teriparatide in biphosphonate-resistant osteoporosis and high fracture risk]
2019	Ontario Health	Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: respiratory multiplex NAAT (8 or more targets)]
2018	NIHR Health Technology Assessment programme	Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT
2018	NIHR Health Technology Assessment programme	Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews
2018	Adelaide Health Technology Assessment (AHTA)	Anti-Mullerian Hormone (AMH) testing for female patients who will or have received gonadotoxic treatment
2018	Andalusian Health Technology Assessment Area (AETSA)	Regorafenib indicated as monotherapy for the treatment of adult patients with hepatocellular carcinoma who have been previously treated with sorafenib. EUnetHTA adopted HTA report.
2018	Basque Office for Health Technology Assessment (OSTEBA)	[HIFU —High intensity focused ultrasound— in essential tremor]
2018	NIHR Health Technology Assessment programme	Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Immunoglobulin in chronic inflammatory demyelinating polyneuropathy and other neurological conditions]
2017	HAYES, Inc.	Impella 2.5 System (Abiomed Inc.) for cardiac support in patients undergoing high-risk percutaneous coronary intervention
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: update of proton radiation therapy indications in oncology]
2017	Norwegian Institute of Public Health (NIPH)	Sutureless aortic valve replacement for treatment of severe aortic stenosis: A single technology assessment of Perceval sutureless aortic valve
2017	Belgian Health Care Knowledge Centre (KCE)	Anticoagulants in non-valvular atrial fibrillation
2017	HAYES, Inc.	Coronary artery calcium scoring for risk assessment and stratification of coronary artery disease in asymptomatic adults
2017	NIHR Health Services and Delivery Research programme	SUPPORT-HF 2 (Seamless User-centred Proactive Provision Of Risk-stratified Treatment for Heart Failure) - An internal pilot phase of a planned large-scale randomised trial of an integrated, technology-enabled care delivery model
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Trabecular bone score-TBS for bone fragility diagnosis]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Evaluation of the utility and indication of prostate biopsies with image fusion – magnetic resonance and transrectal ultrasound]
2016	Health Quality Ontario (HQO)	Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: OHTAC recommendation
2016	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Use of biventricular pacing in atrioventricular heart block
2016	Canary Health Service	[Prognostic genomic tests for localized prostate cancer]
2016	Basque Office for Health Technology Assessment (OSTEBA)	[Prevention of Type 2 Diabetes Mellitus in Primary Health Care through healthy lifestyles: care and recommended clinical interventions]
2016	Basque Office for Health Technology Assessment (OSTEBA)	[Interventions to improve CPAP treatment adherence in patients with obstructive sleep apnea]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[The status and dissemination plan of clinical practice guidelines in Korea]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Pembrolizumab (Keytruda) for PD-L1 strong-positive metastatic non-small cell lung cancer – first line
2015	Haute Autorite de sante (HAS)	[Measurement of nitric oxide (NO) in exhaled air]
2015	NIHR Health Services and Delivery Research programme	The Birthplace in England national prospective cohort study: further analyses to enhance policy and service delivery decision-making for planned place of birth
2015	Agency for Healthcare Research and Quality (AHRQ)	Diagnosis of right lower quadrant pain and suspected acute appendicitis
2015	Health Quality Ontario (HQO)	Is Transient Ischemic Attack a Medical Emergency? OHTAC Recommendation
2015	NIHR Health Technology Assessment programme	Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling
2015	Andalusian Health Technology Assessment Area (AETSA)	Second generation prognostic genomic tests in early breast cancer: EndoPredict® y Prosigna™.
2015	Adelaide Health Technology Assessment (AHTA)	Screening for coronary artery disease using CT calcium scoring
2015	Belgian Health Care Knowledge Centre (KCE)	Non-invasive markers of subclinical atherosclerosis for predicting a primary cardiovascular event: a rapid systematic review
2015	Canary Health Service	[Effectiveness, safety and cost-effectiveness of real-time continuous interstitial glucose monitoring systems (SMCG-TR) for type 1 and 2 diabetes mellitus]
2015	NIHR Health Technology Assessment programme	Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study
2015	Basque Office for Health Technology Assessment (OSTEBA)	[An evaluation of the efficacy of psychosocial techniques (cognitive rehabilitation vs. psychoeducation) as an additional treatment to pharmacological treatment in bipolar disorder]
2014	Adelaide Health Technology Assessment (AHTA)	Bone mineral density analyses using dual energy x-ray absorptiometry (DXA) for women in their 50th year
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Sysadoas. Chondroprotective drugs in the treatment of arthritis]
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Cost-effectiveness of percutaneous aortic valve replacement using prosthetic valve versus the standard surgical treatment]
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparative effectiveness of medication therapies in the rheumatoid arthritis patients]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intravenous ketamine for the treatment of mental health disorders: a review of clinical effectiveness and guidelines
2014	NIHR Health Technology Assessment programme	PRImary care Streptococcal Management (PRISM) study: in vitro study, diagnostic cohorts and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Obesity management interventions delivered in primary care for patients with osteoarthritis: a review of clinical effectiveness
2014	Blue Cross Blue Shield Association (BCBS)	Intra-articular hyaluronic acid for osteoarthritis of the knee
2014	HAYES, Inc.	Corus CAD
2014	Scottish Health Technologies Group (SHTG)	In the context of hypothyroidism, what is the evidence for the effectiveness of diagnostic tests and thyroid hormone replacement therapies?
2013	Health Quality Ontario (HQO)	Transient ischemic attack: where can patients receive optimal care? A rapid review
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Adalimumab, etanercept, infliximab and golimumab for the treatment of ankylosing spondylitis and reactive arthritis]
2013	Basque Office for Health Technology Assessment (OSTEBA)	[Results of the perinatal care of very premature children in the health system of the Basque Country]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Efficacy and safety of percutaneous and transapical aortic valve implantation in the treatment of severe aortic stenosis. Systematic review]
2013	HAYES, Inc.	Prolaris test for prediction of prostate cancer progression
2013	NIHR Health Technology Assessment programme	Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation
2013	HTA Unit, University of Calgary	Use of Oncotype DX for guiding adjuvant chemotherapy decisions in early stage invasive breast cancer patients in Alberta
2013	Agency for Healthcare Research and Quality (AHRQ)	Stroke prevention in atrial fibrillation
2013	Canary Health Service	[Cost-effectiveness review of physiotherapy interventions in knee osteoarthritis]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Aspirin prescription pattern among diabetic patients for prevention of cardiovascular disease]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Cost-effectiveness analysis of a telemonitoring experiment in patients with cardiac insufficiency and chronic obstructive pulmonary disease]